Publication

Article

Surgical Rounds®

March 2014
Volume

Risk Factors Identified for Wound Dehiscence Following Abdominal Laparotomy

Although wound dehiscence is believed to occur in only 0.2-6% of abdominal laparotomies, its associated mortality rate is high.

Although wound dehiscence is believed to occur in only 0.2-6% of abdominal laparotomies, its associated mortality rate is high, ranging from 9-44%. Nevertheless, experts have not yet reached a consensus on the risk factors for dehiscence.

Thus, a team of researchers recently set out to determine the factors that might predispose patients to wound dehiscence after abdominal laparotomy. For their prospective study, which appeared in the January 2014 issue of the Journal of Clinical and Diagnostic Research, the investigators enrolled 50 patients who developed partial or complete wound dehiscence following laparotomy. According to the authors, the majority of the patients were healthy but required emergency surgery.

The researchers identified several significant trends, including:

  • Postoperative wound infection was observed in 90% of patients and considered causative of abdominal wound dehiscence.
  • Renal failure was seen in 38% of patients.
  • Body mass index (BMI) >35 appeared to be a risk factor, as 32% of the patients were obese.
  • Anemia was identified in 26% of patients.
  • Low serum albumin was a contributing factor in 24% of patients.
  • Patients aged 31-40 years were most likely to develop dehiscence, with men at greater risk than women. Twenty-two percent of patients fell into this category.
  • One-fifth of dehiscence patients underwent emergency laparotomy that lasted longer than 2 hours, which was previously identified as a risk factor.

The researchers indicated all study participants had multiple risk factors that contributed to wound dehiscence, across a range of 3-11 factors. They recommended screening for those risk factors and addressing them promptly whenever possible, or increasing monitoring if they cannot be addressed.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.